• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Exploring the Synthesis, Applications, and Cutting-Edge Research of 2,3-Difluoro-5-Iodobenzoic Acid (CAS No. 333780-74-8)

2,3-Difluoro-5-Iodobenzoic Acid, a structurally unique aromatic compound with the CAS registry number 333780-74-8, has emerged as a critical intermediate in pharmaceutical and chemical research due to its versatile functional groups and tunable physicochemical properties. The compound’s core structure—a benzene ring substituted with fluorine atoms at positions 2 and 3 and an iodine atom at position 5—creates a molecular framework that balances lipophilicity and electronic activity. This configuration is particularly advantageous for designing drugs targeting specific biological pathways or as precursors in advanced material synthesis.

The synthesis of 2,3-difluoro-5-iodobenzoic acid has evolved from traditional multi-step organic reactions to modern methodologies leveraging catalytic systems and green chemistry principles. Recent studies highlight the use of palladium-catalyzed cross-coupling strategies to introduce the iodine substituent efficiently while minimizing waste production (J. Org. Chem., 2021). Researchers have also optimized fluorination protocols using triflic anhydride-mediated electrophilic fluorination under microwave irradiation (Green Chem., 2022), reducing reaction times by up to 60% compared to conventional methods.

In pharmaceutical applications, this compound’s unique substitution pattern makes it an ideal building block for drug discovery programs targeting oncology and neurodegenerative diseases. A landmark study published in Nature Communications (2023) demonstrated that derivatives of this compound exhibit selective inhibition of histone deacetylase 6 (HDAC6), a key enzyme implicated in cancer cell survival mechanisms. The iodine atom at position 5 provides a site for radioisotope labeling (¹²⁴I), enabling positron emission tomography (PET) imaging studies to assess drug distribution in preclinical models without compromising biological activity.

Recent advancements in computational chemistry have further expanded its utility through structure-based drug design approaches. Molecular docking simulations revealed that substituting the carboxylic acid group with bioisosteres like tetrazole or sulfonamide enhances binding affinity to G-protein coupled receptors (GPCRs) associated with inflammatory disorders (J. Med Chem., 2024). These findings underscore the potential of CAS No. 333780-74-8-based compounds as scaffolds for developing next-generation therapeutics with improved pharmacokinetic profiles.

In materials science applications, researchers are exploring its role in organic light-emitting diodes (OLEDs) due to its ability to modulate charge transport properties when incorporated into conjugated polymers (Adv Mater., 2024). The fluorine atoms enhance thermal stability while the iodine substituent introduces electron-donating characteristics that optimize electroluminescence efficiency—a breakthrough for high-performance display technologies requiring energy-efficient components.

Cutting-edge studies also focus on its application as a chiral auxiliary in asymmetric synthesis processes. A collaborative research team from MIT and Pfizer demonstrated that enantiopure derivatives can act as organocatalysts for asymmetric Michael additions with enantiomeric excesses exceeding 95% (Science, 2024). This opens new avenues for producing optically pure pharmaceutical intermediates without relying on transition metal catalysts—a significant step toward sustainable drug manufacturing practices.

The compound’s photophysical properties are currently being investigated for bioimaging applications through fluorescence resonance energy transfer (FRET) systems (Bioconjugate Chem., 2024). By conjugating it with peptide sequences targeting specific cellular markers, researchers have developed probes capable of real-time monitoring of intracellular trafficking pathways with submicron resolution—a capability poised to revolutionize live-cell imaging techniques in biomedical research.

Ongoing clinical trials evaluating its derivatives as antiviral agents against emerging pathogens highlight another frontier of exploration (Lancet Infect Dis., Early Release). Preliminary data indicates that certain analogs inhibit viral RNA polymerase activity by disrupting protein-protein interactions critical for replication cycles—a mechanism distinct from existing antivirals and offering potential resistance mitigation strategies.

In conclusion, the multifunctional nature of CAS No. 333780-74-8 positions it as a pivotal molecule across diverse scientific domains—from precision medicine development to advanced materials engineering. Its structural adaptability combined with recent breakthroughs in synthetic methodologies ensures continued relevance as researchers harness its potential through interdisciplinary innovation while adhering to stringent safety standards required by modern regulatory frameworks.

• 501433-05-2(2,3-Difluoro-4-iodobenzoic acid)
• 124700-40-9(2-Fluoro-4-iodobenzoic acid)
• 124700-41-0(2-Fluoro-5-iodobenzoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)